Srenson's thinking was coloured by the fact that a previous drug, Redux, approved in 1996 by the FDA for weight loss and launched with great fanfare, had to be withdrawn a year later after it was found to cause major heart attacks and to be largely ineffective
Csajbk A, Tams G
Liang, C., Xiao, H., Hu, Z., Zhang, X
DrugPatentWatch maintains one of the most comprehensive pharmaceutical patent databases available, tracking patent expiration dates, ANDA filings, litigation outcomes, Orange Book listings, and market exclusivity periods across thousands of molecules [13]
But GLP-1 medications also appear to have anti-inflammatory, vascular, and possibly antithrombotic [blood clot-reducing] effects